We are not yet done with electronic noses for today. The Jerusalem Post is reporting that an instrument manufactured by Oridion Systems Ltd. can noninvasively determine whether a patient has hepatitis C or some other infectious liver disease, with the results available in 40 minutes or so.
The instrument is named Oridion BreathID® and the description of it as follows:
The BreathID® system is unique in many ways. It is able to diagnose and monitor a multitude of functional GI and internal disorders through testing applications such as Helicobacter pylori, Liver Function and Gastric Emptying Rate. The system is ideal for a wide range of patients that suffer from functional dyspepsia, diabetes, Parkinson’s disease, a wide range of liver diseases such as Hepatitis (HCV, HBV), NAFLD, NASH diseases, and those related to alcoholism.
State-of-the-Art Technology and Design for Every Environment
The BreathID’s remarkable benefits and unbeatable performance are a result of its unique and proprietary technologies: Microstream®, MCS™ (Molecular Correlation Spectroscopy) and CRT (Continuous Real Time) technology on-line analysis algorithms. The use of these technologies enables BreathID® to offer several distinct advantages over other testing systems and methods. These advantages include automatic operation, immediate test results, the shortest
possible testing times, no need for active patient cooperation and more clinical information in each measurement due to the continuous sampling.
BreathID® was designed with the needs of both the physician/operator and the patient in mind. Simple single-button operation, self-calibration and a user-friendly interface enable easy test administration by any member of the staff with no need for prior training or orientation.